Cognitive and physical activity and dementia: A 44-year longitudinal population study of women.


Journal

Neurology
ISSN: 1526-632X
Titre abrégé: Neurology
Pays: United States
ID NLM: 0401060

Informations de publication

Date de publication:
19 03 2019
Historique:
received: 01 05 2018
accepted: 14 11 2018
pubmed: 23 2 2019
medline: 18 12 2019
entrez: 22 2 2019
Statut: ppublish

Résumé

To investigate whether cognitive and physical activities in midlife are associated with reduced risk of dementia and dementia subtypes in women followed for 44 years. A population-based sample of 800 women aged 38-54 years (mean age 47 years) was followed from 1968 to 2012. Cognitive (artistic, intellectual, manual, religious, and club) and physical activity were assessed at baseline. During follow-up, dementia (n = 194), Alzheimer disease (n = 102), vascular dementia (n = 27), mixed dementia (n = 41), and dementia with cerebrovascular disease (n = 81) were diagnosed according to established criteria based on information from neuropsychiatric examinations, informant interviews, hospital records, and registry data. Cox regression models were used with adjustment for age, education, socioeconomic status, hypertension, body mass index, cigarette smoking, diabetes mellitus, angina pectoris, stress, and major depression. We found that cognitive activity in midlife was associated with a reduced risk of total dementia (hazard ratio [HR] 0.66; 95% confidence interval [CI] 0.49-0.89) and Alzheimer disease (HR 0.54; 95% CI 0.36-0.82) during follow-up. Physical activity in midlife was associated with a reduced risk of mixed dementia (HR 0.43; 95% CI 0.22-0.86) and dementia with cerebrovascular disease (HR 0.47; 95% CI 0.28-0.78). The results were similar after excluding those who developed dementia before 1990 (n = 21), except that physical activity was then also associated with reduced risk of total dementia (HR 0.67; 95% CI 0.46-0.99). Our findings suggests that midlife cognitive and physical activities are independently associated with reduced risk of dementia and dementia subtypes. The results indicate that these midlife activities may have a role in preserving cognitive health in old age.

Identifiants

pubmed: 30787164
pii: WNL.0000000000007021
doi: 10.1212/WNL.0000000000007021
pmc: PMC6511097
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1322-e1330

Informations de copyright

Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

Références

J Gerontol A Biol Sci Med Sci. 2008 Jan;63(1):62-6
pubmed: 18245762
JAMA. 1996 Feb 21;275(7):528-32
pubmed: 8606473
Curr Alzheimer Res. 2011 Jun;8(4):354-60
pubmed: 21222591
Neurology. 2001 Dec 26;57(12):2236-42
pubmed: 11756603
BMC Public Health. 2015 Oct 24;15:1089
pubmed: 26499254
Alzheimers Dement. 2008 Sep;4(5):324-31
pubmed: 18790459
BMC Public Health. 2012 Aug 24;12:693
pubmed: 22920914
N Engl J Med. 2003 Jun 19;348(25):2508-16
pubmed: 12815136
Arch Neurol. 2000 Jun;57(6):808-13
pubmed: 10867777
Neurology. 2002 Dec 24;59(12):1910-4
pubmed: 12499482
Neurology. 2000;54(11 Suppl 5):S10-5
pubmed: 10854355
Lancet Neurol. 2005 Nov;4(11):705-11
pubmed: 16239176
Alzheimers Dement. 2015 Apr;11(4):434-443.e6
pubmed: 24721528
Acta Med Scand. 1973 Apr;193(4):311-8
pubmed: 4717311
Neurology. 2018 Apr 10;90(15):e1298-e1305
pubmed: 29540588
Neurobiol Aging. 2007 Mar;28(3):343-50
pubmed: 16513221
Am J Epidemiol. 2002 Jun 15;155(12):1081-7
pubmed: 12048221
BMJ. 2017 Jun 22;357:j2709
pubmed: 28642251
Neurology. 2012 Apr 24;78(17):1323-9
pubmed: 22517108
Neurology. 1993 Feb;43(2):250-60
pubmed: 8094895
N Engl J Med. 1993 Jan 21;328(3):153-8
pubmed: 8417380
Am J Epidemiol. 2005 Apr 1;161(7):639-51
pubmed: 15781953
Neurology. 1984 Jul;34(7):939-44
pubmed: 6610841
Arch Neurol. 2012 May;69(5):623-29
pubmed: 22271235
Eur J Epidemiol. 2016 Mar;31(3):267-74
pubmed: 26857126

Auteurs

Jenna Najar (J)

From the Department of Psychiatry and Neurochemistry (J.N., S.O., P.G., V.S., L.J., S.K., X.G., T.H., I.S.), Institute of Neuroscience and Physiology, The Sahlgrenska Academy at Gothenburg University, Mölndal; and the Department of Epidemiology and Social Medicine (V.S.), The Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden. jenna.al-najjar@gu.se.

Svante Östling (S)

From the Department of Psychiatry and Neurochemistry (J.N., S.O., P.G., V.S., L.J., S.K., X.G., T.H., I.S.), Institute of Neuroscience and Physiology, The Sahlgrenska Academy at Gothenburg University, Mölndal; and the Department of Epidemiology and Social Medicine (V.S.), The Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden.

Pia Gudmundsson (P)

From the Department of Psychiatry and Neurochemistry (J.N., S.O., P.G., V.S., L.J., S.K., X.G., T.H., I.S.), Institute of Neuroscience and Physiology, The Sahlgrenska Academy at Gothenburg University, Mölndal; and the Department of Epidemiology and Social Medicine (V.S.), The Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden.

Valter Sundh (V)

From the Department of Psychiatry and Neurochemistry (J.N., S.O., P.G., V.S., L.J., S.K., X.G., T.H., I.S.), Institute of Neuroscience and Physiology, The Sahlgrenska Academy at Gothenburg University, Mölndal; and the Department of Epidemiology and Social Medicine (V.S.), The Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden.

Lena Johansson (L)

From the Department of Psychiatry and Neurochemistry (J.N., S.O., P.G., V.S., L.J., S.K., X.G., T.H., I.S.), Institute of Neuroscience and Physiology, The Sahlgrenska Academy at Gothenburg University, Mölndal; and the Department of Epidemiology and Social Medicine (V.S.), The Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden.

Silke Kern (S)

From the Department of Psychiatry and Neurochemistry (J.N., S.O., P.G., V.S., L.J., S.K., X.G., T.H., I.S.), Institute of Neuroscience and Physiology, The Sahlgrenska Academy at Gothenburg University, Mölndal; and the Department of Epidemiology and Social Medicine (V.S.), The Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden.

Xinxin Guo (X)

From the Department of Psychiatry and Neurochemistry (J.N., S.O., P.G., V.S., L.J., S.K., X.G., T.H., I.S.), Institute of Neuroscience and Physiology, The Sahlgrenska Academy at Gothenburg University, Mölndal; and the Department of Epidemiology and Social Medicine (V.S.), The Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden.

Tore Hällström (T)

From the Department of Psychiatry and Neurochemistry (J.N., S.O., P.G., V.S., L.J., S.K., X.G., T.H., I.S.), Institute of Neuroscience and Physiology, The Sahlgrenska Academy at Gothenburg University, Mölndal; and the Department of Epidemiology and Social Medicine (V.S.), The Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden.

Ingmar Skoog (I)

From the Department of Psychiatry and Neurochemistry (J.N., S.O., P.G., V.S., L.J., S.K., X.G., T.H., I.S.), Institute of Neuroscience and Physiology, The Sahlgrenska Academy at Gothenburg University, Mölndal; and the Department of Epidemiology and Social Medicine (V.S.), The Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH